Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

NCT05889390 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer

Interventions

DEVICE: Oncotherm EHY-2030
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cyclophosphamide/Doxorubicin
PROCEDURE: Breast cancer removal surgery

Sponsor

Semmelweis University